Get the Stockscreener App
327.27
2.08%
6.66
After Hours:
327.27
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $327.27, with a volume of 2.11M.
It is up +2.08% in the last 24 hours and down -10.18% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$320.61
Open:
$319.83
24h Volume:
2.11M
Relative Volume:
1.65
Market Cap:
$63.66B
Revenue:
$325.78B
Net Income/Loss:
$1.64B
P/E Ratio:
39.36
EPS:
8.3139
Net Cash Flow:
$3.61B
1W Performance:
-2.22%
1M Performance:
-10.18%
6M Performance:
+6.13%
1Y Performance:
+22.34%
1-Day Range:
$317.19
$329.02
1-Week Range:
$317.19
$334.57
52-Week Range:
$265.59
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
327.27 | 62.37B | 325.78B | 1.64B | 3.61B | 8.3139 |
MCK
Mckesson Corporation
|
881.94 | 107.42B | 397.96B | 4.55B | 9.64B | 34.77 |
CAH
Cardinal Health Inc
|
207.23 | 48.57B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.02 | 8.54B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.27 | 2.06B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-22-26 | Upgrade | Jefferies | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
UBS reiterates Cencora stock rating on EyeSouth retina deal - Investing.com
Kultura Brands (OTC:LTNC) Accelerates National Momentum With Cencora Marketplace Spring & Summer Growth Acceleration Program - Weatherford Democrat
Kultura pushes Thirst Responder into U.S. pharmacies for April buying season - Stock Titan
Cencora to buy EyeSouth Partners’ retina business (COR:NYSE) - Seeking Alpha
Cencora, Inc. $COR Shares Bought by SG Americas Securities LLC - MarketBeat
Diversified Trust Co. Sells 9,560 Shares of Cencora, Inc. $COR - MarketBeat
Cencora to acquire EyeSouth Partners retina unit for $1.1 billion By Investing.com - Investing.com Australia
Olympus to Sell Retina Business of EyeSouth Partners to Cencora for $1.1 Billion - VisionMonday.com
COR to Broaden Retina Consultants of America Through $1.1B EyeSouth Acquisition - Bitget
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
BofA reiterates Cencora stock rating on retina business expansion By Investing.com - Investing.com Australia
Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1 Billion to Expand Retina Consultants of America - Minichart
Cencora, Inc. (COR) Announces Acquisition of EyeSouth Partners' Retina Business - GuruFocus
Evercore ISI reiterates Cencora stock rating on retina platform deal By Investing.com - Investing.com Australia
Evercore ISI reiterates Cencora stock rating on retina platform deal - Investing.com
BofA reiterates Cencora stock rating on retina business expansion - Investing.com
Cencora to Acquire EyeSouth Retina Business for Expansion - TipRanks
Cencora To Acquire EyeSouth Retina Business For $1.1B - citybiz
Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1B, Slightly Accretive to EPS - TradingView
Cencora (NYSE: COR) to acquire EyeSouth retina business in $1.1B deal - Stock Titan
Cencora to acquire EyeSouth Partners retina unit for $1.1 billion - Investing.com
Cencora to buy retina business of EyeSouth Partners for $1.1 billion - marketscreener.com
Cencora buys EyeSouth's retina business in $1.1 billion deal - Reuters
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - MSN
Nordea Investment Management AB Raises Stake in Cencora, Inc. $COR - MarketBeat
Cencora Inc. stock faces scrutiny amid supply chain pressures and healthcare sector shifts - AD HOC NEWS
Cencora Reaffirms $17 EPS Despite Leadership Shake-Up: Street Sees 25% Upside Ahead - TIKR.com
Profit Recap: Can Cencora Inc grow without external funding2026 Sector Moves & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
COR's MWI Animal Health to merge with Covetrus in $3.5 billion deal - MSN
COR SEC FilingsCencora Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Is It Time To Reassess Cencora (COR) After The Recent Share Price Pullback - simplywall.st
Market Outlook: Is Cencora Inc benefiting from interest rate changesQuarterly Performance Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Groupama Asset Managment Makes New Investment in Cencora, Inc. $COR - MarketBeat
Cencora Inc stock faces pressure amid institutional sales and Q4 earnings review - AD HOC NEWS
CIBC Bancorp USA Inc. Invests $8.33 Million in Cencora, Inc. $COR - MarketBeat
Here's why you should hold Cencora stock in your portfolio for now - MSN
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Here’s Why Cencora (COR) Shares Rose 8% in Q4 - Insider Monkey
Swiss Life Asset Management Ltd Buys 7,905 Shares of Cencora, Inc. $COR - MarketBeat
Park National Corp OH Trims Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora CFO Jim Cleary to retire after years of driving growth - MSN
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora, Inc. $COR Position Lessened by CIBC Private Wealth Group LLC - MarketBeat
A Look At Cencora (COR) Valuation After Recent Share Price Weakness - simplywall.st
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cencora’s animal health unit to merge with Covetrus in $3.5B transaction - MSN
Cencora, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Cencora Releases Fiscal Year 2025 Corporate Responsibility Report, Marking 10 Years of Purpose in Action - CSRwire
CENCORA INC (NYSE:COR) Passes the "Caviar Cruise" Quality Investing Screen - ChartMill
Cencora, Inc. Hits Day Low of $329.03 Amid Price Pressure - Markets Mojo
305,934 Shares in Cencora, Inc. $COR Bought by Danske Bank A S - MarketBeat
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):